Navigation Links
Northeastern's Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC

Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.

The Barnett Institute of Chemical and Biological Analysis, a part of Northeastern University's College of Science, has recognized this need, and has partnered in the formation of BioAnalytix, LLCa company specializing in the application of advanced biologic drug characterization methods and technologies to enable better, faster and more effective drug development and commercialization.

With a strong and experienced board from the analytical sciences and pharmaceutical industry, the Barnett Institute wanted to help create a company that could directly serve pharmaceutical partners in key areas of biologic development. "Beyond its well established research position in advanced analytics, the Barnett Institute has for several yearsbeen working with leading pharmaceutical companies to develop and apply analytical methods in their areas of biologic development, and we continued to see the increasing opportunity to meet this need as a commercially orientedbusiness," said Barry Karger, Director of the Barnett Institute, James L. Waters Chair in Analytical Chemistry.

"It is really a terrific opportunity to bring leading research and advanced analytic capabilities into a business that can directly help improve and accelerate drug development processes, and reduce costs in the healthcare space overall," said BioAnalytix CEO, Kirt Poss.

The affiliation between the Barnett Institute and BioAnalytix will also enable a mutually beneficial opportunity in joint participation in leading research and policy areas, as well as increased project work with partners in combined areas of advanced research and commercial application,providing even more unique and applied opportunities for Northeastern students. "The spin-off of BioAnalytix not only leads to socially beneficial commercial development that we are not suited to do inside a university, but also keeps our research in contact with the cutting edge of technology in the biologic sector," said Murray Gibson, Dean of Northeastern's College of Science.


Contact: Lori Lennon
Northeastern University College of Science

Related medicine news :

1. Penn Translational Medicine Institute to hold 7th Annual Symposium
2. Scripps Research Institute scientists show protein linked to hunger also implicated in alcoholism
3. Weizmann Institutes mathematical model may lead to safer chemotherapy
4. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells
5. Astex, CRT and the Institute of Cancer Research announce epigenetic drug discovery collaboration
6. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
7. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim lead insulation paper
8. Minneapolis Heart Institute Foundation welcomes Europace publication of Optim™ lead insulation paper
9. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
10. JDRF-Helmsley Charitable Trust to fund islet encapsulation research at Diabetes Research Institute
11. A vaccine for heart disease? La Jolla Institute discovery points up this possibility
Post Your Comments:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving ... has dropped below 10,000 for the first time since 2011. In 2014, there were ... to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: